Galli Laura L - OmicsDI

Show results for

Metabolomics (2)
Transcriptomics (1)

Organisms

Mus musculus (1)

Repository

MetaboLights (2)
biostudies-arrayexpress (1)

Technology Type

Mass spectrometry (2)

Instrument Platform

Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - hilic (1)
Liquid Chromatography MS - positive - reverse phase (1)
Q Exactive (1)

Publication Date

2022 (2)
2016 (1)

CHEBI ID

CHEBI:15428 (2)
CHEBI:15611 (2)
CHEBI:15698 (2)
CHEBI:15728 (2)
CHEBI:15891 (2)
CHEBI:15978 (2)
CHEBI:15999 (2)
CHEBI:16020 (2)
CHEBI:16199 (2)
CHEBI:16335 (2)
CHEBI:16359 (2)
CHEBI:16450 (2)
CHEBI:16530 (2)
CHEBI:16628 (2)
CHEBI:16668 (2)
CHEBI:16675 (2)
CHEBI:16704 (2)
CHEBI:16708 (2)
CHEBI:16737 (2)
CHEBI:16750 (2)
CHEBI:16827 (2)
CHEBI:16919 (2)
CHEBI:17012 (2)
CHEBI:17050 (2)
CHEBI:17140 (2)
CHEBI:17154 (2)
CHEBI:17172 (2)
CHEBI:172453 (2)
CHEBI:17287 (2)
CHEBI:17385 (2)

Metabolite Name

O-Tyrosine (2)
(R)-3-hydroxybutyrylcarnitine (1)
1,11-Undecanedicarboxylic acid (1)
1,3-Dimethyluric acid (1)
1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4)* (1)
1-(1-enyl-palmitoyl)-2-linoleoyl-GPE (P-16:0/18:2)* (1)
1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1)* (1)
1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0)* (1)
1-(1-enyl-palmitoyl)-GPE (P-16:0)* (1)
1-(1-enyl-stearoyl)-GPE (P-18:0)* (1)
1-arachidonoyl-GPI (20:4)* (1)
1-lignoceroyl-GPC (24:0) (1)
1-linoleoyl-2-arachidonoyl-GPC (18:2/20:4n6)* (1)
1-linoleoyl-GPC (18:2) (1)
1-linoleoyl-GPE (18:2)* (1)
1-methyl-4-imidazoleacetate (1)
1-methylguanidine (1)
1-methylhistamine (1)
1-methylhistidine (1)
1-methylnicotinamide (1)
1-myristoyl-2-palmitoyl-GPC (14:0/16:0) (1)
1-oleoyl-2-docosahexaenoyl-GPC (18:1/22:6)* (1)
1-oleoyl-2-linoleoyl-GPE (18:1/18:2)* (1)
1-oleoyl-GPI (18:1) (1)
1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* (1)
1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) (1)
1-palmitoyl-2-docosahexaenoyl-GPE (16:0/22:6)* (1)
1-palmitoyl-2-linoleoyl-GPC (16:0/18:2) (1)
1-palmitoyl-2-oleoyl-GPC (16:0/18:1) (1)
1-palmitoyl-2-palmitoleoyl-GPC (16:0/16:1)* (1)

Study type

Transcription profiling by array (1)

Release Date

2016 (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Aberrant L-Fucose accumulation and increased core fucosylation are metabolic liabilities in mesenchymal glioblastoma (Xenograft assays)

Glioblastoma (GBM) is a common and deadly form of brain tumor in adults. Dysregulated metabolism in GBM offers an opportunity to deploy metabolic interventions as precise therapeutic strategies. To identify the molecular drivers and the modalities by which different molecular subgroups of GBM exp...

2022-11-08 | MTBLS730 | MetaboLights

Aberrant L-Fucose accumulation and increased core fucosylation are metabolic liabilities in mesenchymal glioblastoma (Stem cell and cell line assays)

2022-11-08 | MTBLS4708 | MetaboLights

Angiogenesis and Gene Signature in Muscular Hypertrophy

Adult myogenic progenitor cells (activated satellite cells) express both HGF and its receptor cMet. Following muscle injury, autocrine HGF-Met stimulation plays a key role in promoting activation and early division of satellite cells. Magic-F1 (Met-Activating Genetically Improved Chimeric Factor-1) ...

ORGANISM(S): Mus musculus

2016-06-28 | E-GEOD-83771 | biostudies-arrayexpress

Previous page
1 / 1
You're on page 1
Next page